Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

BACKGROUND: The novel coronavirus pandemic calls for a rapid adaptation of conventional medical practices to meet the evolving needs of such vulnerable patients. People with coronavirus disease (COVID-19) may frequently require treatment with psychotropic medications, but are at the same time at hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostuzzi, Giovanni, Papola, Davide, Gastaldon, Chiara, Schoretsanitis, Georgios, Bertolini, Federico, Amaddeo, Francesco, Cuomo, Alessandro, Emsley, Robin, Fagiolini, Andrea, Imperadore, Giuseppe, Kishimoto, Taishiro, Michencigh, Giulia, Nosé, Michela, Purgato, Marianna, Serdar, Dursun, Stubbs, Brendon, Taylor, David, Thornicroft, Graham, Ward, Philip B., Hiemke, Christoph, Correll, Christoph U., Barbui, Corrado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360478/
https://www.ncbi.nlm.nih.gov/pubmed/32664944
http://dx.doi.org/10.1186/s12916-020-01685-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360478/
https://www.ncbi.nlm.nih.gov/pubmed/32664944
http://dx.doi.org/10.1186/s12916-020-01685-9

Ejemplares similares